TRINTELLIX
(https://trintellix.com) 📸 Data Snapshot: June 20, 2026
Information Density — The Lens
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Info Density
Power-words vs. Substance ratio.
22
Impact Weight: 30 / 100
73% Reputation
The body text contains high-value specific nouns like MADRS and HAM-D24, alongside a hard figure of over 2 million patients. However, the density is severely diluted by the massive repetition of IMPORTANT SAFETY INFORMATION (ISI) which appears 8 times across the headings. The body substance ratio suffers as the same 2,297 characters are duplicated across every primary sub-page (Resources, Clinical Data, Request a Rep), resulting in high concept repetition without additional depth.
Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.
📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE (https://trintellix.com) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
2297 chars
SUB-PAGE (https://trintellix.com/resources/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
2297 chars
SUB-PAGE (https://trintellix.com/request-a-rep/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
2297 chars
SUB-PAGE (https://trintellix.com/clinical-data/) TRINTELLIX (vortioxetine) for U.S. Healthcare Providers
TRINTELLIX® (vortioxetine) is indicated for the treatment of Major Depressive Disorder (MDD) in adults. Patient portrayal. Individual results may vary. TRINTELLIX: proven to relieve the overall symptoms of MDD1 Based on MADRS or HAM-D24 total scores, as shown in 6 short-term (6- to 8-week) MDD studies. See Clinical Data HAM-D24, Hamilton Depression 24-item Rating Scale; MADRS, Montgomery-Åsberg Depression Rating Scale Expert Insights Hear your peers discuss MDD, including its impact on speed of processing, and how TRINTELLIX may help. Watch now TRINTELLIX has been prescribed to over 2 million patients in the US.11 Support for your patients We’re here to help your eligible patients get the treatment you prescribe. Explore patient savings Resources for you and your patients Find a range of information, education, and patient resources, as well as industry insights. Explore resources Patient profile Learn more about a patient living with the emotional, physical, and cognitive symptoms of MDD. Read their story Telling patients about telehealth As telehealth visits become more common, it’s important to have helpful resources for you and your patient. Learn more Request a rep visit Connect with a TRINTELLIX representative. Submit a request Long-term clinical data Results from multiple clinical studies of TRINTELLIX. Read the results Offering patients once daily dosing Learning about dosage amounts and drug interactions. Learn more [IMG: Patient quote saying Living with the burden of depression is exhausting. I am looking for relief.] Hear from experts on MDD & how TRINTELLIX may help. HEAR MORE NOT NOW
2297 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…
Explore the other reputation pillars for TRINTELLIX
Analysis Disclosure & Source Attribution
This page presents a snapshot of public data from TRINTELLIX, captured on June 20, 2026, to show how machine logic reads Information Density signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to TRINTELLIX: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://trintellix.com to view the most current version of its content and see directly what this company is about and what it offers.